The HudsonAlpha Institute for Biotechnology, in collaboration with Phenome Health and the Buck Institute for Research on Aging, has launched a pilot study to explore how genetics and lifestyle influence a person’s risk of developing Alzheimer’s disease and related dementias. The study, called HOPE AD (Healthy Outcomes through Phenomic Explorations for Alzheimer’s Disease), is now enrolling participants at the Smith Family Clinic for Genomic Medicine in Huntsville. Faculty Investigator Nick Cochran, PhD, and Meagan Cochran, MS CGC, the Director of the Smith Family Clinic for Genomic Medicine at HudsonAlpha spoke with Ginny Kennedy about this potentially groundbreaking study. More details and information about who is eligible to participate in the study are available here.
How Do Genetics and Lifestyle Affect Risk for Alzheimer's Disease? HudsonAlpha to Launch Pilot Study
